Evidence level: B
「局部还是全身」不是数据自带的属性,它取决于你用什么量「近」。而在这个问题上,经络、体表厘米、探测体积、部位基线、事后归类这五把尺子同时在用,它们给出的答案并不一致。
正文
上一篇把「病人反应更大」拆成几层假象,结论是先别急着比两组幅度。这一篇往前走一步:假设放大确实存在,它长在哪儿?只出现在病灶所在经络的穴位上,还是全身穴位一起变?
这问题听着只换了因变量,其实换掉了整个空间框架。「局部」与「全身」不是测量值,是判断——取决于你用什么尺子量「近」。而这里至少五把尺子同时在用。
第一把:经络。 说「放大局限于胃经」,意思是效应沿一条传统线路分布。可经络不是等距坐标系:穴位间距在四肢与躯干差好几倍,「相关经」与「不相关经」在体表常彼此贴邻。更要紧的是经络分区没法还原成皮节——皮节图本身就不准,现有图谱多基于有缺陷的早期研究,重叠与个体变异被长期低估(PMID 18470936)。所以「胃经」既不等于 L3-L4 皮节,也不等于「膝盖周围十厘米」。把「相关经」当干净二分变量,等于假设三套解剖学恰好重合。
第二把:体表直线距离。 用厘米建模衰减看着最客观,但它默认效应按半径扩散。经络假说恰恰不这么预测:它讲「上病下取」「内属于脏腑,外络于肢节」,远端取穴靠连通而非邻近。于是同一批数据在两把尺子下结论相反:按厘米算远端效应弱,支持「局部」;按经络算足三里对胃、合谷对面口,支持「跨段连通」。这不是数据矛盾,是尺子不同——沿路径的连通与随距离的衰减是两个模型,不能用一个去否证另一个。
第三把:探测体积。 这一把最少被提及。四电极法测的不是一个点,是极板之间那块组织的等效阻抗;针间距、进针深度、皮下胶原带都改变读数(PMID 15882468;PMID 20689594;PMID 12467083 报告穴位与肌间结缔组织隔对应率约八成)。相邻穴位间距常与探测体积相当,「相邻测点」实为同一块组织的重复取样。这在统计上叫伪重复——估计不偏,但标准误被系统性低估,第一类错误率严重偏离名义水平(PMID 21687445:组内相关越高、组数越少,偏离越离谱)。后果具体:「全身广泛变化」可能只是探测体积重叠造成的假扩散,「局限」也可能只是同一个热点被数了三次。
第四把:部位基线。 十个不同体表区域的基线阻抗本就不同,且随年龄系统变化(PMID 27333585)。远端穴位反应小,可能不是「效应传不到」,而是那里基线低、没有下降余地,或电极贴合差、灵敏度低。跨部位比原始阻抗值,等于把部位效应当成距离效应。做法是每个部位都用同部位非穴位点自身对照,只在部位内算差值再比。
第五把:谁算「相关」。 一个膝痛患者,取胃经(梁丘、犊鼻)、胆经(阳陵泉)、脾经(阴陵泉)、膀胱经(委中)都说得通。若「相关经」是看完数据才定,任何结果都能找到一条自洽的经络解释。这是研究者自由度最经典的入口(PMID 27879038;核查标准见 PMID 33296358)。要拦它只有一条路:「相关经」的定义必须在看数据前写死,并写明依据(教科书条文、定位规则还是解剖标志)——允许事后改,就是允许事后编。
五把尺子摆在一起,会露出一个更麻烦的结构问题:部位效应与距离效应高度共线。 若衰减曲线在膝、肩、腰三处形状一致,可以说是「按部位可测性调制」;若曲线随病灶整体平移、始终以病灶为峰,可以说是「局部」。两种解释都能拟合同一批数据,除非在多个病灶部位重复同一套几何——真空间结构会跟着病灶走,部位效应不会。
还有一条不能回避的反向证据:临床上「局部取穴」与「远端取穴」的镇痛效果,在直接比较的研究中未见显著差异(PMID 25690699);催产引产的系统综述里,局部加远端联合与单用远端也无差异(PMID 40801473)。这不能证明穴位没有空间结构,但说明在中观层面「近的比远的强」未被临床数据支持,举证责任在「空间特异性」一侧。
所以该做的不是「相关经 vs 不相关经」的交互项,而是三件更笨的事。一是把距离当连续变量,同时拟合三种距离(体表厘米、经络路径、皮节段差)比边际解释力——若三者接近,说明数据分辨不出空间结构,任何「局限于某经」的结论都不成立。二是显式写入空间结构,用带空间随机效应的多层模型或距离衰减核,不把相邻测点当独立样本;样本量按独立空间单元数算,不按电极数算。三是多部位重复同一几何,让「跟着病灶走」成为可检验的预测,而不是事后的说法。
易学落点。《素问·皮部论》讲「皮者脉之部也」,把体表按经脉分成十二皮部——这是按归属分,不是按远近分。经络从设计上就是一张关系网:上下、内外、表里、原络,讲的是谁连着谁、谁管着谁,不是「离病灶多远」。所以拿厘米检验经络,用的是经络自己没用过的尺子;只用经络标签分组,又丢掉了最核心的信息——方向与连通。真正的检验该问的不是「半径多大」,而是「图上哪条边被点亮了」。
证据与局限
已验证: 穴位与肌间/肌内结缔组织隔存在约八成解剖对应(PMID 12467083),沿经络的皮下胶原带与更低阻抗相关(PMID 20689594;PMID 15882468,但仅心包经显著、脾经不显著);四电极法测得组织阻抗随针间距与深度变化(PMID 15882468;PMID 20689594);体表不同部位基线阻抗差异显著并随年龄系统变化(PMID 27333585);穴位皮肤电阻在健康人中约四成测次与周边不同、方向可高可低,且短期可重复性高、一周后很低(PMID 19422323);同一设备在同一批穴位上的单次测量信度约 0.72-0.76(PMID 15353016);温湿度、取穴标准、仪器操作是公认混杂(PMID 29354942);现有皮节图不准确、重叠与变异被低估(PMID 18470936);忽略层次结构会使第一类错误率严重偏离(PMID 21687445);小样本与研究者自由度共同推高假阳性(PMID 23571845;PMID 27879038;PMID 33296358)。
部分验证: 穴位敏化的动物证据支持「病灶→特定皮节段神经源性炎症」的空间局域性:胃黏膜损伤大鼠的伊文思蓝渗出点集中于 T9-11 皮节,并伴 SP/CGRP 纤维与肥大细胞聚集(PMID 28270193;综述见 PMID 35620665);内脏痛的牵涉与继发痛觉过敏由躯体内脏汇聚神经元敏化解释,可扩散至多个皮节(PMID 24903037;PMID 12817663)。但这些是针刺样敏化点而非阻抗读数,两者是否共用同一空间尺度,尚无直接数据。
待验证: 三种距离模型在同一批接地-阻抗数据上的相对解释力;探测体积重叠造成的空间自相关强度(是否足以单独伪造出「全身扩散」);「多部位重复同一几何」能否把部位效应与距离效应分开;局部与远端取穴在临床镇痛上等效(PMID 25690699;PMID 40801473)与电学层面可能存在空间特异性之间如何调和。
相关阅读
证据等级: B
参考文献: PMID 18470936, PMID 15882468, PMID 20689594, PMID 12467083, PMID 21687445, PMID 27333585, PMID 27879038, PMID 33296358, PMID 25690699, PMID 40801473, PMID 19422323, PMID 15353016, PMID 29354942, PMID 23571845, PMID 28270193, PMID 35620665, PMID 24903037, PMID 12817663
免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。
The Meaning of \”Near\”: Meridian Specificity of Grounding-Acupuncture Point Impedance and Five Conflicting Spatial Scales
Evidence level: B
“Local versus systemic” is not an intrinsic attribute of the data; it depends on which scale you use to measure “nearness.” On this issue, five scales operate simultaneously: the meridian, surface linear distance, probe volume, anatomical baseline, and post-hoc classification. They yield inconsistent answers.
Main Text
The previous article deconstructed “greater patient response” into layers of illusion, concluding that one should not rush to compare magnitudes between groups. This article advances further: assuming amplification exists, where does it grow? Does it appear only on acupoints along the affected meridian, or do all acupoints change systemically?
This question seems to merely swap the dependent variable, yet it replaces the entire spatial framework. “Local” and “systemic” are not measurements; they are judgments dependent on which ruler you use to measure “nearness.” Here, at least five rulers operate simultaneously.
First Ruler: The Meridian. Stating that “amplification is limited to the Stomach Meridian” implies the effect distributes along a traditional pathway. However, meridians are not equidistant coordinate systems: inter-acupoint spacing differs by several times between limbs and the trunk. Furthermore, “related meridians” and “unrelated meridians” often abut each other on the surface. More critically, meridian zoning cannot be reduced to dermatomes—the dermatome maps themselves are inaccurate, and existing charts rely on flawed early studies where overlaps and individual variations have been systematically underestimated (PMID 18470936). Therefore, the “Stomach Meridian” is neither equivalent to the L3-L4 dermatome nor to “ten centimeters around the knee.” Treating the “related meridian” as a clean binary variable assumes three distinct anatomical systems coincide perfectly.
Second Ruler: Surface Linear Distance. Modeling attenuation with centimeters appears most objective, yet it defaults to radial diffusion. The meridian hypothesis predicts otherwise: it posits “treat upper diseases with lower points” and “internal organs belong internally, limbs/joints externally,” relying on connectivity rather than proximity for distal point selection. Consequently, the same dataset yields opposite conclusions under two different rulers: calculating by centimeters shows weak distal effects, supporting “locality”; calculating by meridian shows Zusanli affecting the stomach and Hegu affecting the mouth, supporting “cross-segment connectivity.” This is not a data contradiction but a difference in rulers—pathway connectivity and distance-dependent attenuation are two distinct models; neither can refute the other using a single metric.
Third Ruler: Probe Volume. This ruler is least frequently mentioned. The four-electrode method does not measure a single point but the equivalent impedance of the tissue between the plates; needle spacing, insertion depth, and subcutaneous collagen bands all alter readings (PMID 15882468; PMID 20689594; PMID 12467083 reports an ~80% correspondence rate between acupoints and intermuscular connective tissue). Adjacent acupoint spacing often matches the probe volume; thus, “adjacent measurement points” constitute repeated sampling of the same tissue block. Statistically, this is pseudoreplication—estimates remain unbiased, but standard errors are systematically underestimated, causing severe deviation from nominal Type I error rates (PMID 21687445: higher intra-class correlation and fewer groups lead to greater deviation). The consequence is specific: “systemic widespread changes” may merely be false diffusion caused by overlapping probe volumes, while “locality” may simply be the same hotspot counted three times.
Fourth Ruler: Anatomical Baseline. Baseline impedance across ten different surface regions naturally differs and changes systematically with age (PMID 27333585). Small distal responses may not indicate “failure of effect transmission” but rather low baselines with no room for decrease, poor electrode contact, or low sensitivity. Comparing across regions treats regional effects as distance effects. The correct approach is to use same-region non-acupoint points for internal control within each region, calculating differences only within regions before comparison.
Fifth Ruler: Who Defines “Relevance”. For a patient with knee pain, the Stomach Meridian (Liangqiu, Dubini), Gallbladder Meridian (Yanglingquan), Spleen Meridian (Yinlingquan), and Bladder Meridian (Weizhong) all provide plausible explanations. If the “related meridian” is determined after viewing the data, any result can find a self-consistent meridian explanation. This is the classic entry point for researcher degrees of freedom (PMID 27879038; verification criteria see PMID 33296358). To constrain this, there is only one path: the definition of the “related meridian” must be fixed prior to data viewing, with justification stated (textbook clauses, localization rules, or anatomical landmarks)—allowing post-hoc changes is equivalent to allowing post-hoc fabrication.
Placing all five rulers together reveals a more complex structural issue: high collinearity between regional effects and distance effects. If attenuation curves have consistent shapes at the knee, shoulder, and waist, it can be termed “region-specific measurability modulation”; if curves shift globally with the lesion peak remaining fixed at the lesion site, it can be termed “local.” Both explanations can fit the same dataset unless the same geometric setup is repeated across multiple lesion sites—true spatial structure follows the lesion, whereas regional effects do not.
There is also unavoidable counter-evidence: clinical studies directly comparing analgesic efficacy between “local point selection” and “distal point selection” show no significant difference (PMID 25690699); systematic reviews of labor induction show no difference between combined local and distal use versus distal use alone (PMID 40801473). This does not prove acupoints lack spatial structure, but it indicates that “near is stronger than far” at the meso-level is not supported by clinical data, placing the burden of proof on the “spatial specificity” side.
Therefore, the task is not an interaction term of “related vs. unrelated meridians,” but three more laborious actions. First, treat distance as a continuous variable, simultaneously fitting three distances (surface centimeters, meridian path length, dermatome segment difference) to compare marginal explanatory power—if all three are similar, data cannot resolve spatial structure, and any conclusion of “limitation to a specific meridian” is invalid. Second, explicitly encode spatial structure using multi-level models with spatial random effects or distance-decay kernels, treating adjacent measurement points as non-independent samples; calculate sample size based on independent spatial units, not electrode counts. Third, repeat the same geometry across multiple regions, making “following the lesion” a testable prediction rather than a post-hoc explanation.
Yijing Studies perspective. The Su Wen · Pi Bu Lun states “The skin is the department of the vessels,” dividing the surface into twelve dermatomes according to meridians—this is classification by affiliation, not classification by proximity. Meridians are designed as a relational network: upper/lower, interior/exterior, exterior/internal, original/branching, describing who connects to whom and who governs whom, not “how far from the lesion.” Thus, testing meridians with centimeters uses a ruler the meridian system itself does not employ; grouping solely by meridian labels discards the core information—direction and connectivity. The true test should not ask “what radius,” but “which edges on the map are illuminated.”
Evidence and Limitations
Verified: There is approximately 80% anatomical correspondence between acupoints and intermuscular/intramuscular connective tissue septa (PMID 12467083); subcutaneous collagen bands along meridians correlate with lower impedance (PMID 20689594; PMID 15882468, though significant only for the Pericardium Meridian and not the Spleen Meridian); four-electrode methods show tissue impedance varies with needle spacing and depth (PMID 15882468; PMID 20689594); significant baseline impedance differences exist across surface regions and change systematically with age (PMID 27333585); acupoint skin resistance in healthy individuals varies across ~40% of measurements relative to surroundings with variable direction and high short-term repeatability but very low repeatability after one week (PMID 19422323); inter-device reliability for single measurements on the same batch of acupoints is approximately 0.72-0.76 (PMID 15353016); humidity, temperature, point selection standards, and instrument operation are recognized confounders (PMID 29354942); existing dermatome maps are inaccurate with underestimated overlaps and variations (PMID 18470936); ignoring hierarchical structure causes severe deviation in Type I error rates (PMID 21687445); small sample sizes and researcher degrees of freedom jointly inflate false positives (PMID 23571845; PMID 27879038; PMID 33296358).
Partially Verified: Animal evidence supporting acupoint sensitization supports “lesion-specific dermatome segment neurogenic inflammation” spatial locality: Evans blue extravasation points in rats with gastric mucosal injury concentrate at T9-11 dermatomes accompanied by SP/CGRP fibers and mast cell aggregation (PMID 28270193; review see PMID 35620665); referred pain and secondary hyperalgesia are explained by sensitization of trunk visceral convergence neurons, which can diffuse to multiple dermatomes (PMID 24903037; PMID 12817663). However, these are needle-like sensitization points, not impedance readings; whether they share the same spatial scale lacks direct data.
To Be Verified: Relative explanatory power of the three distance models on the same batch of grounding-impedance data; spatial autocorrelation intensity caused by probe volume overlap (whether sufficient to independently fabricate “systemic diffusion”); whether “repeating the same geometry across multiple regions” can separate regional effects from distance effects; how to reconcile clinical equivalence of local vs. distal point selection for analgesia (PMID 25690699; PMID 40801473) with potential spatial specificity at the electrical level.
Related Reading
- Which ruler measures “greater patient response”?
- Does grounding-induced acupoint impedance change possess acupoint specificity?
- Original design for grounding-acupoint impedance pathology amplification effect
- Acupuncture Points = Electrical Nodes
- Research Pool: Environment-Life Frequency Interface
Evidence Level: B
References: PMID 18470936, PMID 15882468, PMID 20689594, PMID 12467083, PMID 21687445, PMID 27333585, PMID 27879038, PMID 33296358, PMID 25690699, PMID 40801473, PMID 19422323, PMID 15353016, PMID 29354942, PMID 23571845, PMID 28270193, PMID 35620665, PMID 24903037, PMID 12817663
Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.
Leave a Reply